Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Other financing activities: 2023-2024

Historic Other financing activities for CG Oncology (CGON) over the last 2 years, with Dec 2024 value amounting to -$3.4 million.

  • CG Oncology's Other financing activities was N/A to $270,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$314,000, marking a year-over-year change of. This contributed to the annual value of -$3.4 million for FY2024, which is 0.09% down from last year.
  • CG Oncology's Other financing activities amounted to -$3.4 million in FY2024, which was down 0.09% from -$3.4 million recorded in FY2023.
  • In the past 5 years, CG Oncology's Other financing activities ranged from a high of -$3.4 million in FY2023 and a low of -$3.4 million during FY2024.
  • In the last 2 years, CG Oncology's Other financing activities had a median value of -$3.4 million in 2023 and averaged -$3.4 million.
  • Data for CG Oncology's Other financing activities shows a maximum YoY dropped of 0.09% (in 2024) over the last 5 years.
  • Over the past 2 years, CG Oncology's Other financing activities (Yearly) stood at -$3.4 million in 2023, then dropped by 0.09% to -$3.4 million in 2024.